We have presented the evidence that PRDM16 transactivates TRPA1 expression (Figure 3), and TRPA1 suppresses MAPK activation and TGF‐β1 expression in DKD (Figures 5 and 6). Here, TGFB1 is linked to diabetic kidney disease.